Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

The report "Medical Filtration Market by Material (Polyethersulfone; Polyvinylidenefluoride), Applications (Dialysis; Sterile ...

Presents Analysis of Industry Giants, Including Thermo Fisher Scientific, Merck, Danaher Corporation, Sartorius, and Aceto ...

Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.

On February 5, 2025, the first working day of the Year of the Snake, Guangdong held a provincial high-quality development conference in Guangzhou to conduct in-depth exchanges and discussions on ...

Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates.

The Peptide Synthesis market valued at US$ 0.78 Billion in 2023, is forecasted to grow at a robust CAGR of 11.7%, reaching US$ 0.81 Billion in ...

Bank of America Securities analyst Tim Anderson reiterated a Buy rating on Merck & Company (MRK – Research Report) today and set a price target of $118.00. The company’s shares opened today at ...

Jan 30 (Reuters) - Merck (MRK.N), opens new tab plans to stop ... is already approved for treating the rare condition which causes high blood pressure in the lungs, leading to symptoms such ...

We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other Kevin ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, reaching US$ ...